Endothelial colony-Forming cells derived from pregnancies complicated by intrauterine growth restriction are fewer and have reduced vasculogenic capacity

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 12, 2013, Pages 4953-4960

  Sipos, Peter I ^a   Bourque, Stephane L ^a   Hubel, Carl A ^b   Baker, Philip N ^c   Sibley, Colin P ^a   Davidge, Sandra T ^c   Crocker, Ian P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; STROMAL CELL DERIVED FACTOR 1;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSPORT; CHEMOTAXIS; CLINICAL ARTICLE; COLONY FORMING CELL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME RELEASE; ENZYME SYNTHESIS; FEMALE; FLOW CYTOMETRY; GESTATIONAL AGE; HUMAN; HYPOXIA; IN VIVO STUDY; INTRAUTERINE GROWTH RETARDATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DETERMINATION; PROTEIN FUNCTION; ZYMOGRAPHY;

CAPILLARIES; CARDIOVASCULAR DISEASES; CELL COUNT; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS; COHORT STUDIES; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; FEMALE; FETAL BLOOD; FETAL GROWTH RETARDATION; FETAL STEM CELLS; HUMANS; MATRIX METALLOPROTEINASE 2; NEOVASCULARIZATION, PATHOLOGIC; PLACENTA; PREGNANCY; PROSPECTIVE STUDIES;

EID: 84889839167     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2580     Document Type: Article

References (28)

1. Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells usinghumanperipheral and umbilical cord blood. Blood. 2004;104(9):2752-2760.
2. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest. 2000;105(1):71-77.
3. Sipos PI, Crocker IP, Hubel CA, Baker PN. Endothelial progenitor cells: Their potential in the placental vasculature and related complications. Placenta. 2010;31(1):1-10.
4. Romo A, Carceller R, Tobajas J. Intrauterine growth retardation (IUGR): Epidemiology and etiology. Pediatr Endocrinol Rev. 2009; 6(Suppl 3):332-336.
5. Chen CP, Bajoria R, Aplin JD. Decreased vascularization and cell proliferation in placentas of intrauterine growth-restricted fetuses with abnormal umbilical artery flow velocity waveforms. Am J Obstet Gynecol. 2002;187(3):764-769.
6. Mayhew TM, Ohadike C, Baker PN, Crocker IP, Mitchell C, Ong SS. Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. Placenta. 2003;24(2-3):219-226.
7. Kiserud T, Ebbing C, Kessler J, Rasmussen S. Fetal cardiac output, distribution to the placenta and impact of placental compromise. Ultrasound Obstet Gynecol. 2006;28(2):126-136.
8. Sipos PI, Rens W, Schlecht H, et al. Uterine vasculature remodeling in human pregnancy involves functional macro-chimerism by endothelial colony forming cells of fetal origin. Stem Cells. 2013;31(7): 1363-1370.
9. Sanderson DA, Wilcox MA, Johnson IR. The individualised birthweight ratio: A new method of identifying intrauterine growth retardation. Br J Obstet Gynaecol. 1994;101(4):310-314.
10. Wilcox MA, Johnson IR, Maynard PV, Smith SJ, Chilvers CE. The individualised birthweight ratio:Amore logical outcome measure of pregnancy than birthweight alone. Br J Obstet Gynaecol. 1993; 100(4):342-347.
11. Mead LE, Prater D, Yoder MC, Ingram DA. Isolation and characterization of endothelial progenitor cells from human blood. Curr Protoc Stem Cell Biol. 2008;Chapter 2:Unit 2C.1.
12. Melero-Martin JM, Bischoff J. Chapter 13. An in vivo experimental model for postnatal vasculogenesis. Methods Enzymol. 2008;445: 303-329.
13. Duda DG, Cohen KS, Scadden DT, Jain RK. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc. 2007; 2(4):805-810.
14. Cheng XW, Kuzuya M, Nakamura K, et al. Mechanisms underlying the impairment of ischemia-induced neovascularization in matrix metalloproteinase 2-deficient mice. Circ Res. 2007;100(6):904- 913.
15. Basire A, Sabatier F, Ravet S, et al. High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors. Thromb Haemost. 2006;95(4):678-688.
16. Ingram DA, Lien IZ, Mead LE, et al. In vitro hyperglycemia or a diabetic intrauterine environment reduces neonatal endothelial colony- forming cell numbers and function. Diabetes. 2008;57(3):724- 731.
17. Ligi I, Simoncini S, Tellier E, et al. A switch toward angiostatic gene expression impairs the angiogenic properties of endothelial progenitor cells in low birth weight preterm infants. Blood 2011;118(6): 1699-1709.
18. Shen L, Gao Y, Qian J, et al. The role of SDF-1alpha/Rac pathway in the regulation of endothelial progenitor cell polarity; homing and expression of Rac1, Rac2 during endothelial repair. Mol Cell Biochem. 2012;365(1-2):1-7.
19. Wu Y, Dai J, Schmuckler NG, et al. Cleaved high molecular weight kininogen inhibits tube formation of endothelial progenitor cells via suppression of matrix metalloproteinase 2. J Thromb Haemost. 2010;8(1):185-193.
20. Barker DJ, Eriksson JG, Forsén T, Osmond C. Fetal origins of adult disease: Strength of effects and biological basis. Int J Epidemiol. 2002;31(6):1235-1239.
21. Rueda-Clausen CF, Morton JS, Davidge ST. The early origins of cardiovascular health and disease: who, when, and how. Semin Reprod Med. 2011;29(3):197-210.
22. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005; 353(10):999-1007.
23. Huang L,HouD, ThompsonMA,et al. Acute myocardial infarction in swine rapidly and selectively releases highly proliferative endothelial colony forming cells (ECFCs) into circulation. Cell Transplant. 2007;16(9):887-897.
24. Jiga J, Hoinoiu B, Stoichitoiu T, et al. Induction of therapeutic neoangiogenesis using in vitro-generated endothelial colony-forming cells: an autologous transplantation model in rat. J Surg Res. 2013; 181(2):359-368.
25. Schwarz TM, Leicht SF, Radic T, et al. Vascular incorporation of endothelial colony-forming cells is essential for functional recovery of murine ischemic tissue following cell therapy. Arterioscler Thromb Vasc Biol. 2012;32(2):e13- e21.
26. Campioni D, Zauli G, Gambetti S, et al. In vitro characterization of circulating endothelial progenitor cells isolated from patients with acute coronary syndrome. PLoS One. 2013;8(2):e56377.
27. Meneveau N, Deschaseaux F, Séronde MF, et al. Presence of endothelial colony-forming cells is associated with reduced microvascular obstruction limiting infarct size and left ventricular remodeling in patients with acute myocardial infarction. Basic Res Cardiol. 2011;106(6):1397-1410.
28. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348(7):593-600.